Arlington Partners’s CVS Health CVS Stock Holding History

Arlington Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,572	Closed	-$109K	–	436
2023 Q2	$109K	Sell	1,572 -656	-29%	-$46.7K	0.02%	233
2023 Q1	$166K	Buy	2,228 +1,700	+322%	+$143K	0.02%	144
2022 Q4	$49.2K	Hold	528	–	–	0.01%	218
2022 Q3	$50K	Sell	528 -432	-45%	-$42.8K	0.02%	193
2022 Q2	$89K	Buy	960 +432	+82%	+$42.2K	0.03%	179
2022 Q1	$53K	Buy	528 +100	+23%	+$10.5K	0.02%	241
2021 Q4	$44K	Buy	+428	New	+$39.6K	0.01%	292
2020 Q2	–	Sell	-46	Closed	-$3K	–	191
2020 Q1	$3K	Buy	+46	New	+$3.07K	﹤0.01%	217
2019 Q2	–	Sell	-5,418	Closed	-$292K	–	225
2019 Q1	$292K	Buy	+5,418	New	+$334K	0.21%	42
2018 Q4	–	Sell	-1,000	Closed	-$79K	–	222
2018 Q3	$79K	Buy	+1,000	New	+$71.5K	0.06%	105

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arlington Partners's CVS Position: Q3 2023 in Review

Arlington Partners sold out of CVS Health (CVS) in Q3 2023, closing a stake of 1,572 shares — an estimated $109K sold.

Arlington Partners first reported a position in CVS in Q3 2018 and held it in 10 quarters. The position peaked at $292K in Q1 2019. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

Arlington Partners reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
Arlington Partners sold 1,572 CVS Health shares in Q3 2023, an estimated $109K.
Arlington Partners first reported a position in CVS Health in Q3 2018 and held it in 10 quarters.
Arlington Partners's CVS Health position peaked at $292K in Q1 2019.
2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Arlington Partners's 13F filing for Q3 2023, filed 24 Oct 2023.